Iain Dukes

Iain Dukes is a highly experienced professional in the biotechnology and pharmaceutical sectors, currently serving as CEO of Viriom Inc and Theseus Pharmaceuticals, and as Chairman of the Board for Iovance Biotherapeutics, Inc. and KaNDY Therapeutics, Ltd. Iain Dukes also holds board positions at ReViral, Ltd., ENYO Pharma, Kyn Therapeutics, Inc., and NeRRE Therapeutics, Ltd., along with the role of Venture Partner at OrbiMed. With an extensive academic background, Iain Dukes earned a BSc in Pharmacology from the University of Bath, an MSc in Cardiovascular Studies from the University of Leeds, a DPhil in Physiology/Pharmacology from the University of Oxford, and an MA in Jurisprudence from the University of Oxford.